Pharmacogenomics-Guided Precision Therapy for Chronic Kidney Disease with Resistant Hypertension: A Prospective Cohort Study.

Kidney Blood Press Res · 2026 · PMC12845529 · PMID 41363682

Europe PMC DOI

hedged sentences

0.1110

closest p · 2.2× alpha

0.1110

boldest claim

The sentences

a favorable trendp = 0.111not close (p > 0.1)

2 d), and the MAP target achievement rate showed a favorable trend (51.16% vs. 27.27%, p = 0.111) ( Fig. 2 b).

also in 1,335 other papers

showed a trendno p-value reported

By the 18th month, the Empirical group showed a trend toward improvement in SBP (27.90% vs. 13.63%), DBP (58.13% vs. 45.45%), and MAP target achievement rates (41.86% vs. 31.81%), though the differences were not statistically significant and were accompanied by considerable blood pressure fluctuations.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.